Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Neuromodulation. 2012 Jul 2;15(6):508–519. doi: 10.1111/j.1525-1403.2012.00479.x

Figure 7.

Figure 7

The blood pressure and heart rate responses observed during the continuous intrathecal infusion of ziconotide. From 0 to 48 hr, ziconotide was infused at 1 µg/hr. From 48 to 96 hr, ziconotide was delivered at the rate of 5 µg/hr. Results presented represent the mean and SEM of data from 5 dogs.